Alessandro Tomelleri to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Alessandro Tomelleri has written about Antibodies, Monoclonal, Humanized.
Connection Strength
0.132
-
Respiratory Impairment Predicts Response to IL-1 and IL-6 Blockade in COVID-19 Patients With Severe Pneumonia and Hyper-Inflammation. Front Immunol. 2021; 12:675678.
Score: 0.048
-
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med. 2020 06; 76:43-49.
Score: 0.045
-
Anti-PD1 therapy-associated cutaneous leucocytoclastic vasculitis: A case series. Eur J Intern Med. 2018 11; 57:e11-e12.
Score: 0.039